Moneycontrol PRO

business

Cadila rebounds but brokerages cut EPS forecast on USFDA warning

CLSA downgraded the stock to underperform from outperform with reduced target price at Rs 355 (from Rs 473 per share earlier). The brokerage also reduced US business estimates by 17/20 percent for FY17/18 that resulted in cutting EPS expectations by 19 percent for FY17/18.

first published: Jan 1, 2016 02:03 pm

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347